Tizanidine

Product NDC: 58517-380
11-digit product format: 585170380
Labeler code: 58517
Product ID: 58517-380_4ed0bea5-7cc0-4c59-9517-6628c53a27b4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Tizanidine
Dosage form: TABLET
Route: ORAL
Labeler: New Horizon Rx Group, LLC
Application: ANDA076416
Marketing category: ANDA
Marketing start: 2013-08-25
Marketing end: 0000-00-00
Substance: TIZANIDINE
Active strength: 4 mg/1
Pharmacologic classes: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	58517-380		I	Inactivated by FDA		2026-08-11
excluded package	package	58517-380	58517-380-30	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58517-380-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58517-380-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58517-380-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58517-380-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58517-380-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58517-380-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58517-380-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58517-380-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58517-380-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58517-380-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58517-380-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58517-380-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58517-380-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58517-380-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58517-380-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58517-380-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58517-380-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58517-380-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58517-380-30	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58517-380-30	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	58517-380-30	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	58517-380-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076416-001	TIZANIDINE HYDROCHLORIDE	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB		2003-09-29
A076416-002	TIZANIDINE HYDROCHLORIDE	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB		2003-09-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A076416-001	AB
A076416-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076416-001	TIZANIDINE HYDROCHLORIDE	EQ 2MG BASE	TABLET / ORAL	AB	2003-09-29	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076416-002	TIZANIDINE HYDROCHLORIDE	EQ 4MG BASE	TABLET / ORAL	AB	2003-09-29	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076416-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076416-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076416-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076416-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076416-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076416-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076416-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076416-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076416-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076416-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076416-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076416-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076416-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076416-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076416-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076416-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076416-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076416-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076416-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076416-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076416-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076416-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076416-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076416-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076416-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076416-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076416-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076416-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076416-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076416-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076416-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076416-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076416-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076416-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076416-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076416-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076416-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076416-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076416-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076416-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a0ff02d8-b711-423c-b7d1-ada00d81c743	Product name	1	20250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01	Product name	8	20250313
b404127e-1c01-47bb-874e-db1e0b6bd9af	Product name	4	20250313

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58517-380-30	2020-01-31	C162847	48780-1	9d75b9d0-1da7-f424-e053-dadaa90a57ce	Tizanidine Tablets, USP Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
58517-380-30	Tizanidine	30 in 1 BOTTLE	TABLET	30		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58517-380-30	EA - Each	58517-380	231c73c1-288b-4b98-87b0-de2b8a1af0e1	1	2013-11-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TIZANIDINE	ACTIVE INGREDIENT	6AI06C00GW	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
TIZANIDINE	ACTIVE MOIETY	6AI06C00GW	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58517-380	TIZANIDINE TABLET [NEW HORIZON RX GROUP, LLC]	3	Legacy NDC, 1 package rows	20131228_d0182933-afae-4db4-9aa1-a869dcf39658.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 21 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tizanidine	TIZANIDINE	Aphena Pharma Solutions - Tennessee, LLC	25db7cc0-604c-3d6b-e063-6394a90a337f	2026-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Medcore LLC	14bcfbac-8f6a-42af-b3a4-ba10d99f2468	2026-04-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	REMEDYREPACK INC.	f041e5f7-c138-4622-98bf-881f9a649a26	2026-04-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	fefe8332-32eb-4b81-978f-b23b334d7d57	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Northwind Health Company, LLC	f32f399f-42af-f0ba-e053-2a95a90a8c2e	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	PD-Rx Pharmaceuticals, Inc.	fd16a25c-67b6-ae6c-e053-6394a90aeee0	2025-10-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	PD-Rx Pharmaceuticals, Inc.	fdf4f09d-4537-a438-e053-6394a90a573d	2025-10-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	73269d77-16b5-4787-9a7d-1b8688623436	2025-05-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Asclemed USA, Inc.	2f460275-565f-4737-a3df-bf80b9acc268	2025-05-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Direct_rx	2a91884a-39c3-f7ac-e063-6394a90ade14	2025-02-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine HCL	TIZANIDINE HCL	Advanced Rx of Tennessee, LLC	af73c6ab-6c1c-94d1-e053-2a95a90a4e3c	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	e13292b0-9858-4405-8787-a2392d1b6d75	2024-08-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	5f8a5b21-4adb-4f2c-91ae-bc33c3810752	2024-01-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	dd3bf952-50b1-4d50-9073-57fd6888053b	2023-12-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	81501cb1-0a76-4bd0-8eee-dbd1e4a0b69f	2023-12-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	51da17a0-63d2-44fb-a79d-a3bee862e028	2023-11-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	03fa03a6-fd05-4f17-872a-3c123330935d	2023-11-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Bryant Ranch Prepack	5a5b6614-038f-4e5b-9543-0497872c7882	2023-09-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Proficient Rx LP	76dc85bd-3cde-4940-a99b-663b70bf9f54	2022-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416
Tizanidine	TIZANIDINE	Proficient Rx LP	20424d92-5ca1-4114-bc51-1f07c3bed6be	2021-03-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076416 application number: ANDA076416

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6AI06C00GW	TIZANIDINE	51322-75-9	TIZANIDINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313413	tiZANidine HCl 4 MG Oral Tablet	PSN	d0182933-afae-4db4-9aa1-a869dcf39658	3
313413	tizanidine 4 MG Oral Tablet	SCD	d0182933-afae-4db4-9aa1-a869dcf39658	3
313413	tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral Tablet	SY	d0182933-afae-4db4-9aa1-a869dcf39658	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
58517-380-30	58517038030	30 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Tizanidine Tablets, USP Rx only	New Horizon Rx Group, LLC \| CARACO PHARMACEUTICAL LABORATORIES, LTD.	2013-12-27	HUMAN PRESCRIPTION DRUG LABEL	3